GlassScriptPhysician profile
Angelo J Campagna
NPI 1508821638
$3,999.71
in general payments reported to CMS, 2019-2025
31 companies · $487 in 2025
The $487 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $234 · 2021: $359 · 2022: $746 · 2023: $712 · 2024: $829 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,808 · Education: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,807.78 |
| Education | $220.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $658.58 | 2022-2024 | Veozah |
| Gilead Sciences, INC. | $563.56 | 2022-2024 | Epclusa |
| Abbvie INC. | $310.91 | 2019-2023 | Lo Loestrin Fe |
| Shield Therapeutics INC | $272.35 | 2024-2025 | |
| Exeltis, USA INC. | $268.57 | 2019-2025 | Slynd |
| Pfizer INC. | $206.42 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $200.94 | 2022-2025 | |
| Therapeuticsmd, INC. | $189.96 | 2019-2022 | |
| Amgen INC. | $177.99 | 2019-2024 | Prolia, Evenity |
| Exact Sciences Corporation | $159.23 | 2023-2024 | Cologuard Collection Kit |
| Organon LLC | $123.38 | 2023-2025 | Nexplanon, Nuvaring, Jada System |
| Merck Sharp & Dohme LLC | $122.43 | 2019-2024 | Gardasil, Gardasil 9 |
| Agile Therapeutics, INC. | $76.20 | 2021-2022 | |
| Avion Pharmaceuticals | $74.04 | 2019-2020 | |
| Millicent US INC | $64.24 | 2019-2025 | Femlyv |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $63.31 | 2021-2022 | |
| Hologic Sales and Service, LLC | $62.42 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $60.49 | 2020-2023 | |
| Biogen, INC. | $49.86 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $44.86 | 2019-2025 | Paragard T 380a |
| Lupin INC. | $36.65 | 2019 | |
| Vertical Pharmaceuticals, LLC | $32.69 | 2019 | |
| Sumitomo Pharma America, INC. | $27.66 | 2025 | Myfembree |
| Evofem Biosciences, INC. | $23.77 | 2021 | |
| Daiichi Sankyo INC. | $20.59 | 2021 | |
| Cosette Pharmaceuticals INC. | $20.25 | 2024 | Vyleesi |
| Roche Diagnostics Corporation | $19.25 | 2021 | |
| Convatec INC. | $19.02 | 2023 | |
| Avanos Medical | $17.96 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $17.68 | 2023 | Vivjoa |
| Amag Pharmaceuticals, INC. | $14.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Campagna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.